181 related articles for article (PubMed ID: 16470171)
1. Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients.
Zhang B; Zheng R; Wang J; Bu D; Zhu X
J Invest Dermatol; 2006 Apr; 126(4):832-40. PubMed ID: 16470171
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus.
Wang J; Bu DF; Li T; Zheng R; Zhang BX; Chen XX; Zhu XJ
Br J Dermatol; 2005 Sep; 153(3):558-64. PubMed ID: 16120143
[TBL] [Abstract][Full Text] [Related]
3. Detection of anti-envoplakin and anti-periplakin autoantibodies by ELISA in patients with paraneoplastic pemphigus.
Huang Y; Li J; Zhu X
Arch Dermatol Res; 2009 Oct; 301(10):703-9. PubMed ID: 18820940
[TBL] [Abstract][Full Text] [Related]
4. Detection and characterization of anti-envoplakin linker autoantibodies in paraneoplastic pemphigus using specific bead-based assay.
Mouquet H; Drenovska K; Lartigue A; Joly P; Drouot L; Thomas M; Tron F; Gilbert D
Clin Immunol; 2008 Nov; 129(2):304-12. PubMed ID: 18790674
[TBL] [Abstract][Full Text] [Related]
5. Role of autoantibodies against the linker subdomains of envoplakin and periplakin in the pathogenesis of paraneoplastic pemphigus.
Li J; Bu DF; Huang YC; Zhu XJ
Chin Med J (Engl); 2009 Mar; 122(5):486-95. PubMed ID: 19323896
[TBL] [Abstract][Full Text] [Related]
6. The members of the plakin family of proteins recognized by paraneoplastic pemphigus antibodies include periplakin.
Mahoney MG; Aho S; Uitto J; Stanley JR
J Invest Dermatol; 1998 Aug; 111(2):308-13. PubMed ID: 9699735
[TBL] [Abstract][Full Text] [Related]
7. Extremities of the N-terminus of envoplakin and C-terminus of its linker subdomain are major epitopes of paraneoplastic pemphigus.
Wang X; Chen T; Zhao J; Peng Y; Chen X; Tu P; Zhu X; Liu Z; Wang M
J Dermatol Sci; 2016 Oct; 84(1):24-29. PubMed ID: 27427435
[TBL] [Abstract][Full Text] [Related]
8. Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus.
Probst C; Schlumberger W; Stöcker W; Recke A; Schmidt E; Hashimoto T; Zhu XJ; Zillikens D; Komorowski L
Clin Chim Acta; 2009 Dec; 410(1-2):13-8. PubMed ID: 19737550
[TBL] [Abstract][Full Text] [Related]
9. Detection of autoantibodies to periplakin and envoplakin in paraneoplastic pemphigus but not idiopathic pulmonary fibrosis using full-length recombinant proteins.
Muro Y; Sugiura K; Shiraki A; Ishii N; Hashimoto T; Akiyama M
Clin Chim Acta; 2014 Feb; 429():14-7. PubMed ID: 24275244
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for the c-terminal homologous domain of periplakin.
Nagata Y; Karashima T; Watt FM; Salmhofer W; Kanzaki T; Hashimoto T
J Invest Dermatol; 2001 Apr; 116(4):556-63. PubMed ID: 11286623
[TBL] [Abstract][Full Text] [Related]
11. Envoplakin and periplakin are the paraneoplastic pemphigus antigens.
Kiyokawa C
Kurume Med J; 1999; 46(1):71-8. PubMed ID: 10319615
[TBL] [Abstract][Full Text] [Related]
12. Envoplakin and periplakin, the paraneoplastic pemphigus antigens, are also recognized by pemphigus foliaceus autoantibodies.
Kazerounian S; Mahoney MG; Uitto J; Aho S
J Invest Dermatol; 2000 Sep; 115(3):505-7. PubMed ID: 10951291
[No Abstract] [Full Text] [Related]
13. Paraneoplastic pemphigus in children and adolescents.
Mimouni D; Anhalt GJ; Lazarova Z; Aho S; Kazerounian S; Kouba DJ; Mascaro JM; Nousari HC
Br J Dermatol; 2002 Oct; 147(4):725-32. PubMed ID: 12366419
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Newly Available ELISA for Envoplakin Autoantibodies for the Diagnosis of Paraneoplastic Pemphigus.
Powell JG; Grover RK; Plunkett RW; Seiffert-Sinha K; Sinha AA
J Drugs Dermatol; 2015 Oct; 14(10):1103-6. PubMed ID: 26461820
[TBL] [Abstract][Full Text] [Related]
15. Human autoantibodies against HD1/plectin in paraneoplastic pemphigus.
Proby C; Fujii Y; Owaribe K; Nishikawa T; Amagai M
J Invest Dermatol; 1999 Feb; 112(2):153-6. PubMed ID: 9989789
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors of paraneoplastic pemphigus.
Leger S; Picard D; Ingen-Housz-Oro S; Arnault JP; Aubin F; Carsuzaa F; Chaumentin G; Chevrant-Breton J; Chosidow O; Crickx B; D'incan M; Dandurand M; Debarbieux S; Delaporte E; Dereure O; Doutre MS; Guillet G; Jullien D; Kupfer I; Lacour JP; Leonard F; Lok C; Machet L; Martin L; Paul C; Pignon JM; Robert C; Thomas L; Weiller PJ; Ferranti V; Gilbert D; Courville P; Houivet E; Benichou J; Joly P
Arch Dermatol; 2012 Oct; 148(10):1165-72. PubMed ID: 22801794
[TBL] [Abstract][Full Text] [Related]
17. Periplakin and envoplakin are target antigens in canine and human paraneoplastic pemphigus.
de Bruin A; Müller E; Wyder M; Anhalt GJ; Lemmens P; Suter MM
J Am Acad Dermatol; 1999 May; 40(5 Pt 1):682-5. PubMed ID: 10321593
[TBL] [Abstract][Full Text] [Related]
18. Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex.
Kiyokawa C; Ruhrberg C; Nie Z; Karashima T; Mori O; Nishikawa T; Green KJ; Anhalt GJ; DiColandrea T; Watt FM; Hashimoto T
J Invest Dermatol; 1998 Dec; 111(6):1236-8. PubMed ID: 9856851
[No Abstract] [Full Text] [Related]
19. cDNA cloning of the 210-kDa paraneoplastic pemphigus antigen reveals that envoplakin is a component of the antigen complex.
Kim SC; Kwon YD; Lee IJ; Chang SN; Lee TG
J Invest Dermatol; 1997 Sep; 109(3):365-9. PubMed ID: 9284106
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic pemphigus.
Zhu X; Zhang B
J Dermatol; 2007 Aug; 34(8):503-11. PubMed ID: 17683379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
